Report overview
Myocardial perfusion imaging is an imaging device which work non-invasively to show the blood flow, myocardial perfusion imaging also known as nuclear cardiology test. The main function of this imaging to show the blood flow to muscle of heart or myocardium and to identify the absence or presence of CAD (coronary artery disease). Myocardial perfusion imaging show 3D image. Myocardial perfusion imaging two technique, such as PET (positron emission tomography) and SPECT (single photon emission computed tomography). Myocardial perfusion imaging is useful in checking of chest discomfort for facing problem in blood flow to muscle of heart that is caused by angina (blocked in heart arteries) or by narrow in the arteries vessels. The myocardial perfusion imaging process as a small amount of radioactive material is injected that can travel to muscle of heart, then the scan process started to monitor the flow. The Myocardial perfusion imaging testing manage to treat the CAD (coronary artery disease) for medical therapy and revascularization process.
This report aims to provide a comprehensive presentation of the global market for Myocardial Perfusion Imaging (MPI) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Myocardial Perfusion Imaging (MPI) Testing. This report contains market size and forecasts of Myocardial Perfusion Imaging (MPI) Testing in global, including the following market information:
Global Myocardial Perfusion Imaging (MPI) Testing Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Myocardial Perfusion Imaging (MPI) Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is holding the major segment of the market.
We surveyed the Myocardial Perfusion Imaging (MPI) Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Myocardial Perfusion Imaging (MPI) Testing Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Myocardial Perfusion Imaging (MPI) Testing Market Segment Percentages, by Type, 2022 (%)
Stress Myocardial Perfusion Imaging (MPI)
Resting Myocardial Perfusion Imaging (MPI)
Global Myocardial Perfusion Imaging (MPI) Testing Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Myocardial Perfusion Imaging (MPI) Testing Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Ambulatory Surgery Centers
Global Myocardial Perfusion Imaging (MPI) Testing Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Myocardial Perfusion Imaging (MPI) Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Myocardial Perfusion Imaging (MPI) Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Myocardial Perfusion Imaging (MPI) Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Siemens
Koninklijke Philips
Convergent Imaging
SurgicEye GmbH
Lantheus Medical Imaging
Spectrum Dynamics Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Myocardial Perfusion Imaging (MPI) Testing, market overview.
Chapter 2: Global Myocardial Perfusion Imaging (MPI) Testing market size in revenue.
Chapter 3: Detailed analysis of Myocardial Perfusion Imaging (MPI) Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Myocardial Perfusion Imaging (MPI) Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
